Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

Hov,
Thanks.
Just a quick estimate of how much this deal could be worth. Annually, about 800 to 900 new cases of osteosarcoma in the US. Most of them will be treated via surgeries, chemo and radiation. Say, Advaxis gets 10% of the market or about 100 patients. Cost? Likely, they can charge $50K to $80K per year. That’s about $5M to $8M per annum. Valuation at 3x of sales- $15M to $24M to the market cap.
Anyone salivating about tens or even hundreds of millions of dollars upfront cash for this deal is delirious.